[Tumor markers and their use in gynecologic oncology].
The following specific tumour markers used in female patients affected by neoplasm of the genital system are described, such as: CA-125, pheritin, beta--HCG, UGF, CEA and AFP. A continuous postoperative follow-up of all cited tumour markers has been made at the Clinic of Gynecology and Obstetrics at the Faculty of Medicine in Novi Sad from January 1989. Each of the cited tumour markers has been individually described and the explanation pertaining to the validity of individual onco-markers for the specific kind of tumour has been given.